In-Silico Design of Novel Glucagon-Like Peptide 1 Mutants as Candidate for New Peptide Agonist Drugs
The binding of glucagon-like peptide 1 (GLP-1) incretin hormone and its receptor GLP-1R plays an important role in the human body. The GLP-1 acts as the insulin secretion stimulator through a GLP-1R agonist activation to avoid the type 2 diabetes mellitus problem. A recent development in computation...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | EJournal Article |
| Published: |
Bogor Agricultural University, Indonesia,
2021-01-01.
|
| Subjects: | |
| Online Access: | Get fulltext |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Get fulltext3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |